COVID-19 Vaccine Trial Paused, Due To Illness In One Volunteer
A large study of a COVID-19 vaccine candidate has been put on hold after one of the volunteers became ill.
by Joe Palca
Sep 08, 2020
1 minute
Drug maker AstraZeneca has announced that it is pausing its COVID-19 vaccine trial due to a "potentially unexplained illness" in one of the trial volunteers.
The vaccine was developed by the University of Oxford in partnership with Astra Zeneca. It's being studied
You’re reading a preview, subscribe to read more.
Start your free 30 days